Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
VEON settles class action lawsuit to resolve allegations stemming from 2016 FCPA resolutions
May 25, 2026
News Alert
SEC closes FCPA investigation into Methode Electronics
May 19, 2026
News Alert
SFO reaches £15 million settlement with Ultra Electronics to resolve bribery investigation
May 5, 2026
News Alert